960 related articles for article (PubMed ID: 15604286)
1. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
[TBL] [Abstract][Full Text] [Related]
2. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated.
Cowell IG; Durkacz BW; Tilby MJ
Biochem Pharmacol; 2005 Dec; 71(1-2):13-20. PubMed ID: 16293233
[TBL] [Abstract][Full Text] [Related]
4. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
[TBL] [Abstract][Full Text] [Related]
5. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt.
Li Y; Yang DQ
Mol Cancer Ther; 2010 Jan; 9(1):113-25. PubMed ID: 20053781
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
Cariveau MJ; Tang X; Cui XL; Xu B
Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
[TBL] [Abstract][Full Text] [Related]
7. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
[TBL] [Abstract][Full Text] [Related]
9. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
[TBL] [Abstract][Full Text] [Related]
10. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition.
Ćmielová J; Havelek R; Vávrová J; Řezáčová M
Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
12. Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling.
Katsuyama M; Iwata K; Ibi M; Matsuno K; Matsumoto M; Yabe-Nishimura C
Toxicology; 2012 Sep; 299(1):55-9. PubMed ID: 22627294
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.
Kurz EU; Douglas P; Lees-Miller SP
J Biol Chem; 2004 Dec; 279(51):53272-81. PubMed ID: 15489221
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells.
Goodarzi AA; Lees-Miller SP
DNA Repair (Amst); 2004 Jul; 3(7):753-67. PubMed ID: 15177184
[TBL] [Abstract][Full Text] [Related]
15. Ku70/80 modulates ATM and ATR signaling pathways in response to DNA double strand breaks.
Tomimatsu N; Tahimic CG; Otsuki A; Burma S; Fukuhara A; Sato K; Shiota G; Oshimura M; Chen DJ; Kurimasa A
J Biol Chem; 2007 Apr; 282(14):10138-45. PubMed ID: 17272272
[TBL] [Abstract][Full Text] [Related]
16. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
[TBL] [Abstract][Full Text] [Related]
17. Functional switching of ATM: sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells.
Li Y; Xiong H; Yang DQ
Chin J Cancer; 2012 Aug; 31(8):364-72. PubMed ID: 22739265
[TBL] [Abstract][Full Text] [Related]
18. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
19. Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
Zakikhani M; Bazile M; Hashemi S; Javeshghani S; Avizonis D; St Pierre J; Pollak MN
PLoS One; 2012; 7(11):e49513. PubMed ID: 23185347
[TBL] [Abstract][Full Text] [Related]
20. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
Chwastek J; Jantas D; Lasoń W
Int J Biochem Cell Biol; 2017 Jun; 87():38-53. PubMed ID: 28341201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
